Jeremy Capalungan

Jeremy Capalungan has over 25 years of work experience in the field of scientific research and drug discovery. Jeremy currently holds the position of Senior Scientist in the Drug Discovery division at Cajal Neuroscience. In this role, their responsibilities include contributing to the development of new drugs and leading scientific research projects.

Prior to their current position, Jeremy worked as a Senior Staff Scientist at Neoleukin Therapeutics from 2022 to 2023. Here, they led the Bioanalytical group and provided support for protein immunotherapy clinical and research programs. Jeremy also managed bioanalytical methods performed at contract research organizations (CROs) for Neoleukin's clinical program.

From 2010 to 2022, Jeremy worked as a Senior Scientist at Dendreon. In this role, they developed and transferred analytical assays used in clinical studies and for the release of Provenge®, an autologous cellular immunotherapy for advanced prostate cancer. Jeremy also supported various departments including Quality Control, Process Science, and Clinical Immunology.

Jeremy's earlier work experience includes roles at PATH, ZymoGenetics, Primal, Inc., Washington National Primate Center, and Harborview Medical Center. These positions provided him with valuable experience in research and laboratory techniques.

Overall, Jeremy Capalungan's work experience demonstrates a strong background in scientific research, drug discovery, and bioanalytical methods. Jeremy has contributed to the development of new therapies in the field of immunotherapy and has a track record of successfully managing scientific projects.

Jeremy Capalungan has a Bachelor of Science in Microbiology from the University of Washington.